Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aurora Biosciences (ABSC) -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (351)	4/19/2001 6:15:21 PM
From: Richard Belanger	Read Replies (1) \| Respond to of 359

<``Aurora's Big Biology platform leads the industry in the capacity and efficiency it can bring to the discovery process and adds significant value to IPI's growing estate of discovery technologies for high-throughput interrogation of target function and structure,'' stated John D. Mendlein, Ph.D., Integrative Proteomics' chairman and chief executive officer. > He could have added: "And I should know, since I was Aurora's Chief Knowledge Officer until recently."